Business

February 3, 2014 6:29 PM

Cornerstone shareholders approve Chiesi merger

Cornerstone Therapeutics stockholders approved the Cary drug developer’s merger with Italy’s Chiesi Farmaceutici on Monday.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Search Jobs

Enter Keyword(s)

Enter a City

Enter a State